Clinicoepidemiological Profile of Retinopathy of Prematurity

Sasmita Sahu1, Sharmistha Behera1, Gurudev Bishi1

  • 1Department of Ophthalmology, Veer Surendra Sai Institute of Medical Sciences and Research, Burla, Sambalpur, IND.

Cureus
|October 22, 2024
PubMed

Insights

Retinopathy of prematurity (ROP) affects nearly half of preterm infants, with higher birth weights and gestational ages increasing susceptibility. Screening criteria should expand to include these infants, especially those with risk factors like sepsis and respiratory distress syndrome.

Area of Science:

  • Ophthalmology
  • Neonatology
  • Pediatrics

Background:

  • Retinopathy of prematurity (ROP) is a significant concern in preterm infants, with increasing global prevalence.
  • Mechanical ventilation and oxygen dependence are linked to ROP development.
  • Despite improved neonatal care, ROP risk factors persist, necessitating further clinical investigation.

Purpose of the Study:

  • To determine the clinical and epidemiological profile of retinopathy of prematurity (ROP).
  • To identify risk factors and adverse events associated with ROP in preterm infants.

Main Methods:

  • An observational, cross-sectional study involving 268 preterm infants.
  • Data collected from the Department of Ophthalmology and Neonatal Intensive Care Unit.
  • Ethical approval obtained prior to study commencement.

Main Results:

  • ROP developed in 46% of the infants, primarily stage 1 and 2.
  • Lower birth weight (<1500g) and gestational age were significant predictors of ROP.
  • Associated adverse events included sepsis (53%), RDS (54.6%), IVH (60%), and anemia (61.5%).

Conclusions:

  • Higher birth weight and gestational age do not preclude ROP development.
  • Expanded screening criteria for ROP are recommended for infants up to 1750g and >34 weeks gestation.
  • Infants with risk factors like sepsis, RDS, and anemia require vigilant ROP screening.